AJP - Endo Watch the video to see how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 292: E92-E100, 2007. First published August 8, 2006; doi:10.1152/ajpendo.00617.2005
0193-1849/07 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
292/1/E92    most recent
00617.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pendergrass, M.
Right arrow Articles by DeFronzo, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pendergrass, M.
Right arrow Articles by DeFronzo, R. A.

Muscle glucose transport and phosphorylation in type 2 diabetic, obese nondiabetic, and genetically predisposed individuals

Merri Pendergrass,1 Alessandra Bertoldo,2 Riccardo Bonadonna,3 Gianluca Nucci,2 Lawrence Mandarino, Claudio Cobelli,2 and Ralph A. DeFronzo1

1University of Texas Health Science Center, San Antonio, Texas; 2Department of Information Engineering, University of Padova, Padua; and 3Division of Endocrinology and Metabolic Diseases, Verona School of Medicine, Verona, Italy

Submitted 6 December 2005 ; accepted in final form 21 July 2006

Our objectives were to quantitate insulin-stimulated inward glucose transport and glucose phosphorylation in forearm muscle in lean and obese nondiabetic subjects, in lean and obese type 2 diabetic (T2DM) subjects, and in normal glucose-tolerant, insulin-resistant offspring of two T2DM parents. Subjects received a euglycemic insulin (40 mU·m–2·min–1) clamp with brachial artery/deep forearm vein catheterization. After 120 min of hyperinsulinemia, a bolus of D-mannitol/3-O-methyl-D-[14C]glucose/D-[3-3H]glucose (triple-tracer technique) was given into brachial artery and deep vein samples obtained every 12–30 s for 15 min. Insulin-stimulated forearm glucose uptake (FGU) and whole body glucose metabolism (M) were reduced by 40–50% in obese nondiabetic, lean T2DM, and obese T2DM subjects (all P < 0.01); in offspring, the reduction in FGU and M was ~30% (P < 0.05). Inward glucose transport and glucose phosphorylation were decreased by ~40–50% (P < 0.01) in obese nondiabetic and T2DM groups and closely paralleled the decrease in FGU. The intracellular glucose concentration in the space accessible to glucose was significantly greater in obese nondiabetic, lean T2DM, obese T2DM, and offspring compared with lean controls. We conclude that 1) obese nondiabetic, lean T2DM, and offspring manifest moderate-to-severe muscle insulin resistance (FGU and M) and decreased insulin-stimulated glucose transport and glucose phosphorylation in forearm muscle; these defects in insulin action are not further reduced by the combination of obesity plus T2DM; and 2) the increase in intracelullar glucose concentration under hyperinsulinemic euglycemic conditions in obese and T2DM groups suggests that the defect in glucose phosphorylation exceeds the defect in glucose transport.

insulin resistance; muscle; glucose phosphorylation; type 2 diabetes; obesity



Address for reprint requests and other correspondence: R. A. DeFronzo, Univ. of Texas Health Science Center, Diabetes Division, 703 Floyd Curl Dr., San Antonio, TX 78229







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.